Browsing by Author "Moreno Yanes, Silvia Marcela"

Filter results by typing the first few letters
Now showing 1 - 1 of 1
  • Thumbnail Image
    Item
    Intervención farmacéutica en la optimización del uso de antimicrobianos restringidos mediante capacitación en áreas de unidosis del Hospital de Especialidades José Carrasco Arteaga de la ciudad de Cuenca
    (Universidad de Cuenca, 2024-01-23) Moreno Yanes, Silvia Marcela; Molina Matute, Marcos Fernando
    Background: Antimicrobial resistance is a growing health threat and, unless action is taken, the burden of deaths from this cause could reach 10 million per year by 2050. Objective: Optimize the use of restricted antimicrobials through training in single-dose areas of the José Carrasco Arteaga Specialty Hospital in Cuenca. Method: Prospective and intervention study. The work was carried out between February and April 2023; and reports on restricted antimicrobials were implemented, both in prescription and therapeutics, through a pharmaceutical training intervention for single-dose pharmacists, which sought to improve knowledge and skills in this matter and incorporate the pharmacist into the Antimicrobial Optimization Program (PROA). In both the pre-intervention and post-intervention phases, professionals filled out a knowledge evaluation questionnaire, as well as the respective records. Results: The pharmaceutical report obtained most frequently during the pre-intervention phase was a request for restrictive authorization (42.2%), and in the post-intervention phase days of treatment (69%). After the evaluation of the talk, an improvement of one point was observed, with an excellent rating. In reporting effectiveness, a rate of 41.3% was reached in the pre-intervention stage and 58.7% in the post-intervention stage. The economic benefit for the Hospital in the postintervention phase was $2,344.90 US dollars. Conclusions: These results favor the role of the pharmacist in the PROA team, since probably in the future he will be in charge of providing data on the consumption of restricted use antimicrobials and reporting indicators periodically.